checkAd

     732  0 Kommentare Positive Federal Legislation Could Lead to Exponential Growth in Marijuana and CBD Industry - Seite 3

    CARA just released a transcript of their Q1 earnings call: https://finance.yahoo.com/news/edited-transcript-cara-earnings-conference-122442595.html

    Innovative Industrial Properties, Inc. (NYSE: IIPR)

    Anzeige 
    Handeln Sie Ihre Einschätzung zu AbbVie!
    Long
    157,48€
    Basispreis
    1,37
    Ask
    × 11,62
    Hebel
    Short
    194,59€
    Basispreis
    2,26
    Ask
    × 7,05
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Innovative Industrial Properties, Inc. is the leading provider of creative real estate capital solutions to the medical cannabis industry.   Recently the company announced that it closed on the acquisition of a property located at 2000 Rosanna Avenue in Scranton, Pennsylvania, which comprises approximately 89,000 square feet of industrial space.  The purchase price of the property was approximately $5.8 million.  The company's security is only about 5% off of its 52 week high.  

    Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)

    Market Cap: $141.17M, current share price: $10.41 

    ZYNE, a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare and near-rare neurological and psychiatric disorders with high unmet medical needs, is reporting new longer term open label clinical data today in the Emerging Science session of the 2018 Annual Meeting of the American Academy of Neurology (AAN) in Los Angeles, CA.

    In a poster presentation entitled, "Transdermal Cannabidiol (CBD) Gel for the Treatment of Focal Epilepsy in Adults" (poster P4.468), Dr. John Messenheimer presents additional data from ongoing STAR 2 (Synthetic Transdermal CAnnabidiol for the TReatment of Epilepsy) 24-month open label extension study evaluating ZYN002 cannabidiol (CBD) transdermal gel in adult patients with focal seizures. The presentation includes data through twelve months of open label exposure to ZYN002.

    Lesen Sie auch

    Content Provided By: Microcap Speculators

    Email: info@microcapspecualtors.com

    Phone: 1-702-720-6310

    Website: http://microcapspeculators.com/

    For Full Legal Disclaimer Click Here.

    DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.

    Seite 3 von 4



    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Positive Federal Legislation Could Lead to Exponential Growth in Marijuana and CBD Industry - Seite 3 LAS VEGAS, May 2, 2018 /PRNewswire/ - FN Media Group Presents Microcapspeculators.com News Commentary  USA Today recently reported that "America's fast-growing marijuana industry appears poised for supercharged growth after winning what cannabis …